Pro PG receives S19A approval for SULFA AND TRIM Rising 400mg/80mg and 800mg/160mg Tabs

Dear Healthcare Professional,

Shortage of RESPRIM FORTE trimethoprim/sulfamethoxazole 160 mg/800 mg tablet blister pack

Pro Pharmaceuticals Group recognises the importance of supplying essential medicines in Australia and would like to advise you of the change in supply status of RESPRIM FORTE trimethoprim/sulfamethoxazole 160 mg/800 mg tablet blister pack in Australia.

The Australian registered medicine, RESPRIM FORTE trimethoprim/sulfamethoxazole 160 mg/800 mg tablet blister pack AUST R: 17682 Sponsored by Alphapharm Pty Ltd is currently in shortage due to manufacturing issues.

Pro Pharmaceuticals Group has arranged for the supply of alternative products, Sulfamethoxazole and Trimethoprim Tablets, USP 800 mg/160 mg (Rising, USA) and Sulfamethoxazole and Trimethoprim Tablets, USP 400 mg/80 mg (Rising, USA). These products are NOT registered in Australia and supply is authorised under an exemption granted by the Therapeutic Goods Administration (TGA) under section 19A of the Therapeutic Goods Act 1989 until 28th February 2023

Pre-Orders only at this stage and domestic delivery rates may apply

Registered Pro Pharm Member Pharmacies can Log into our website www.propg.com.au and visit Pharmacy Online Ordering to see Product Details including Pricing, Availability and also do any Pre-Orders.

Not a Registered Pro Pharm Member? Then Register Today by visiting our website and going to Pharmacy Online Ordering.

Please note Pro Pharmaceuticals Group is a Wholesaler and not a Pharmacy and can not supply to members of the Public, if you are a member of the Public please visit your Pharmacy to discuss.